Learn / DRUG
NASDAQ: DRUG
Bright Minds Biosciences (DRUG) stock, explained like you're 5
Bright Minds Biosciences trades on the Nasdaq under the ticker DRUG. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 531 million dollars.
- Ticker
- DRUG
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 531 million dollars
Is Bright Minds Biosciences a small, medium or large cap company?
No. Bright Minds Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 531 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Bright Minds Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves DRUG stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- 3 AI Drug Discovery Stocks Retail Investors Are Watching Now (Simply Wall Street)
- Belite Bio Stock In Focus After Stargardt Drug Filings In Three Markets (Yahoo Finance)
- Democrats say Trump increased investments in drugmakers that were given Medicare exemptions (PBS)
- Novartis Scraps Another Drug Study. Why the Stock Is Holding Steady. (Barron's)
- Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 6.6% Here's Why (MarketBeat)
Follow DRUG in your daily brief
Each trading day at 5 PM ET we post what happened to Bright Minds Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow DRUG
Questions about Bright Minds Biosciences stock
What does Bright Minds Biosciences do?
Bright Minds Biosciences trades on the Nasdaq under the ticker DRUG. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 531 million dollars.
What is the ticker symbol for Bright Minds Biosciences?
Bright Minds Biosciences trades under the ticker DRUG on the Nasdaq.
What is Bright Minds Biosciences's market cap?
Bright Minds Biosciences is a small cap stock with a market cap of about 531 million dollars.
How does Bright Minds Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves DRUG stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow DRUG stock every day?
Add DRUG to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.